To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

United States第118届国会HR-3839House of Representatives
更新于：2023年6月9日

摘要

暂无摘要。

法案文本

可用版本
Introduced (House)查看官方文本

有 1 个可用版本

已显示全部可用记录。

时间线

  1. Introduced in House

  2. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

已显示全部可用记录。